Fierce Pharma Asia—Moderna's scrapped Japanese plant; Rexulti's adcomm setback; Pfizer's option in 3SBio

25th July 2025 Uncategorised 0

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck’s proposal for Rexulti as part of a PTSD treatment was rejected by an FDA advisory committee. Pfizer’s PD-1xVEGF deal with 3SBio includes an option agreement. And more.

More: Fierce Pharma Asia—Moderna's scrapped Japanese plant; Rexulti's adcomm setback; Pfizer's option in 3SBio
Source: fierce